Thoratec Overview

  • Founded
  • 1979
  • Status
  • Acquired/​Merged
  • Employees
  • 786
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2
  • Investments
  • 10

Thoratec General Information


Thoratec Corporation incorporated in the State of California in 1976 provides mechanical circulatory support with a product portfolio to treat the full range of clinical needs for advanced heart failure patients. It develops, manufactures and markets proprietary medical devices used for circulatory support. Following the sale of ITC in 2010, the Company has one operating segment: Cardiovascular group. This segment is organized and operates to develop and manufacture mechanical circulatory products to support the cardiovascular systems of humans. The Company's VAD products primarily serve patients suffering from late-stage HF. HF is a chronic disease that occurs when degeneration of the heart muscle reduces the pumping power of the heart, causing the heart to become too weak to pump blood at a level sufficient to meet the body's demands. Hospitals that perform open heart surgery and heart transplants are the potential customers for its Thoratec and HeartMate products. The Company estimates that it sells into 293 of these centers. According to the Company's estimates, it is in approximately 149 centers in the United States and 144 centers internationally. Competition from medical device companies and medical device divisions of healthcare companies, pharmaceutical companies and gene- and cell-based therapies is intense and is expected to increase. It therefore continues to expect new competitors both from the pharmacological and the medical device space. Among the medical device competitors are Aachen Innovative Solutions GmbH, AbioMed, Inc., Berlin Heart GmbH, HeartWare International Inc., Jarvik Heart, Inc., Maquet Cardiovascular, LLC (a division of Getinge AB), MicroMed Technology, Inc., Sun Medical Technology Research Corporation, SynCardia Systems, Inc., and Terumo Heart, Inc. All of the Company's proposed products will require regulatory approval prior to commercialization. In particular, medical devices are subject to rigorous pre-clinical testing as a condition of approval by the FDA and by similar authorities in foreign countries.

Contact Information

Formerly Known As
Thoratec Laboratories Corporation
Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Former Stock Listing
Primary Office
  • 6035 Stoneridge Drive
  • Pleasanton, CA 94588
  • United States
+1 (925) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Thoratec Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Thoratec‘s full profile, request access.

Request a free trial

Thoratec Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Thoratec Corporation incorporated in the State of California in 1976 provides mechanical circulatory support with a prod
Therapeutic Devices
Pleasanton, CA
786 As of 2015
0.00 0000-00-00


im veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis a
00000000000 0000000
Redwood City, CA
00 As of 0000
00000000 00000


do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
00000000000 0000000
Pittsburgh, PA
00 As of 0000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Thoratec Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Avinger Formerly VC-backed Redwood City, CA 00 00000 00000000 00000
00000 Venture Capital-Backed Pittsburgh, PA 00 00000 00000000000 00000
0000 0000000 Formerly PE-Backed Harrison, NY 000 0000 00000000 0000
000000000 Corporation Minneapolis, MN 00000 00000000
00000000 Corporation Carlsbad, CA 000 000000 - 000
You’re viewing 5 of 12 competitors. Get the full list »

Thoratec Executive Team (9)

Name Title Board Seat Contact Info
David Lehman JD Senior Vice President, General Counsel & Secretary
Andrew Hall JD General Counsel
Lawrence Cohen President
Taylor Harris Vice President & Chief Financial Officer
You’re viewing 4 of 9 executive team members. Get the full list »

Thoratec Board Members (8)

Name Representing Role Since
000000 0000 Self Director 000 0000
000000 00000 Self Board of Director 000 0000
0000 000000 Thoratec Board Member 000 0000
0000 0000000000 Self Board Member 000 0000
000000 000000 Self Board of Director 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Thoratec Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Thoratec Investments & Acquisitions (10)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 0000000 21-Sep-2015 00000 00000 00 0000 Therapeutic Devices
00000 000000000000 02-Jul-2014 000000000000000000 0000 Surgical Devices 0000000 0000000
000000 00000 01-Jul-2013 000000000000000000 000.00 Therapeutic Devices 0000000 0000000
0000000000 (000000 03-Aug-2011 000000000000000000 00000 Surgical Devices 0000000 0000000
Corvia Medical 30-Jun-2009 Early Stage VC 00.000 Therapeutic Devices
You’re viewing 5 of 10 investments and acquisitions. Get the full list »

Thoratec Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 21-Apr-2008 00000 00000 00 00.00 Completed
  • 00000000
00000 000000000000 19-Dec-2007 00000 00000 00 0000 Completed
  • 6 buyers
BioCardia 30-Mar-2004 Early Stage VC 00.000 Completed
  • 4 buyers
To view Thoratec’s complete exits history, request access »